NCT07188220Recruiting
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
Perspectives on the Multidisciplinary Approach to Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study With Patients From the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona
Source: ClinicalTrials.gov · Last updated 23 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona. The main research question is: What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention? Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25 (estimated)
- First submitted
- 30 Jul 2025
- Start date
- 3 Jun 2025
- Primary completion date
- 20 Dec 2027
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07188220
What you commit to
- Study type: Observational
- Planned participants: 25
- From 3 Jun 2025 to the primary completion date, 20 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are candidates for bariatric surgery.
Other illness
- Patients with type 1 diabetes or other forms of diabetes.
- Patients with active malignancy.
- Patients with advanced or unstable heart failure.
- Patients with eating disorders or severe psychiatric illness.
Lab values
- Patients with an eGFR \< 30 mL/min.
Other
- Patients who do not agree to participate in the study-specific interviews.
- Patients meeting exclusion criteria of the MASH-Cardiovascular Programme:
- Patients with decompensated liver cirrhosis.
- Patients who are vegetarians or have dietary habits/preferences that prevent adherence to standard-of-care nutritional guidelines.
- Patients with moderate-to-severe alcohol consumption (\>20 g/day for women and \>40 g/day for men).
- Patients with malnutrition.
- Patients currently enrolled in another clinical trial.
- Pregnant women or women planning to become pregnant.
Who the study is looking for
- Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme.
- Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4.
- Patients aged between 18 and 75 years.
- Patients with a BMI ≥ 27 kg/m².
- Patients who consent to participate in the study-specific interviews.
Age in the registry: 18 years to 75 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IR Sant Pau Coordinator of this site? Confirm its status | Barcelona | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.